Leading drug companies staying in single digit growth in 2006.

As a result of local pharmaceutical business recession, the leading drug companies seemed to adopt more conservative management strategies of seeking internal stabilities instead of the growth.

According to the 2006 management report analysis of the leading pharmaceutical stock listed companies having their fiscal year ended at Dec. 31, the sales grew up merely 7.7% at 4,452,100 million wo...